Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 91, Issue 2, 2002, Pages 164-167

  Lee, K Y ^a   Han, Ji Whan ^a   Lee, J S ^a   Whang, K T ^a  

^a Daejeon St Mary's Hospital   (South Korea)

Author keywords

HDL cholesterol; Intravenous immunoglobulin; Kawasaki disease; Lipids; Proteins

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN;

ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; INFANT; LIPID BLOOD LEVEL; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

C-REACTIVE PROTEIN; CHILD, PRESCHOOL; CHOLESTEROL, HDL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 0036196289     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352502317285153     Document Type: Article

References (21)

1. The use of intravenous immune globulin in immunodeficiency disease
2. High dose intravenous gamma globulin therapy for Kawasaki syndrome
3. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhoood
4. Fate of coronary aneurysms in Kawasaki disease: Serial coronary angiography and long-term follow-up study
5. Coronary arterial lesions of Kawasaki disease: Cardiac catheterization findings of 1100 cases
6. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of Kawasaki syndrome
7. Serum HDL-cholesterol and lipoprotein fraction in Kawasaki disease (acute mucocutaneous lymph node syndrome)
8. Altered lipid profile after Kawasaki syndrome
9. Serum cholesterol levels during and after Kawasaki disease
10. Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease
11. Immunologic alterations of peripheral mononuclear cells by intravenous immunoglobulin in the acute stage of Kawasaki disease
12. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetics and safety studies in monkeys and humans
13. Pharmacokinetics of single and multiple infusions of 5S intravenous immunoglobulin
14. Pharmacokinetic characteristics and novel intravenous immunoglobulin preparation
15. Changes in serum lipoprotein pattern induced by acute infection
16. Serum HDL level at acute stage of Kawasaki disease
17. High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man: Evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase
18. Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin
19. Inflamatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: Relationship to cardiac lesions and intravenous immunoglobulin treatment
20. Elimination of infectious antigens and increase of IgG catabolism as possible mode of action of IVIg
21. Mechanism of intravenous immune globulin therapy